SEARCH

Current Edition

Alexion

AstraZeneca reports study success for rare disease drug acquired in Alexion deal

Should detailed study results bear out ALXN1480’s benefit and lead to an FDA approval, the experimental drug could become an important new option for people …

Continue Reading →